Early adopter Teleflex benefits from comprehensive view of patient referral pathways to fast-track greater adoption of its breakthrough innovation in men’s health
AcuityMD, the MedTech Intelligence Platform, announced a new solution that will help MedTech companies and healthcare providers (HCPs) deliver new treatment options to more patients. Referral Pathways in AcuityMD Care Journeys provides comprehensive patient referral data so MedTech commercial teams can easily identify the physicians who can most benefit from their products and bring innovations to more patients.
Referral Pathways in AcuityMD Care Journeys provides comprehensive patient referral data so MedTech commercial teams can easily identify the physicians who can most benefit from their products and bring innovations to more patients
Health Technology Insights: Precision AQ Expands Access Experience Team with Oncology Experts
AcuityMD Care Journeys, launched in October 2024, was designed to help MedTech companies demonstrate the improved clinical and financial outcomes their technology delivers for patients with complex diagnoses and treatment journeys – helping them drive product adoption with hospitals and physicians. Now, AcuityMD is expanding its solution with sophisticated, data-driven visualizations to empower MedTech companies to connect upstream referrers to the HCPs offering their differentiated treatments. It gives a more complete view of the care journey, enabling teams to better target their innovations and improve outcomes for more patients.
Supporting Overburdened Physicians
According to a 2024 survey, 80% of physicians report being overworked. An aging patient population and more patients with comorbidities (i.e., obesity plus diabetes, asthma, sleep apnea, and kidney disease), combined with a serious physician shortage, makes it difficult for providers to stay current on the latest medical innovations. At the same time, MedTech companies are developing new technologies, thanks to advances in AI, robotics, and digital, at an unprecedented clip – in fact, the industry is expected to grow to $800 billion by 2030.
The volume of innovation can overwhelm providers who are already feeling strained by high case volume, staffing challenges, and administrative responsibilities. They simply do not always have time to uncover the latest treatment options for their patients, nor research local doctors providing these new treatments and the outcomes patients are experiencing.
Health Technology Insights: CytoAgents Completes Cohort 1 Dose-Escalation in Clinical Phase 1B for Cytokine Release Syndrome Research
MedTech companies have attempted to bridge this gap by hosting regional and local educational events with HCPs, but information blind spots remain. Comprehensive referral data is often lacking because it only captures a patient’s most recent encounter. MedTech companies struggle to find all relevant HCPs who impact the patient journey, causing some patients to miss out on more effective treatments simply due to a lack of physician awareness.
With AcuityMD’s new Referral Pathways in Care Journeys, MedTech companies gain a comprehensive view of a provider’s entire referral network to deliver better, consultative support.
“Referral Pathways takes MedTech commercialization to the next level, helping companies not only understand the clinical opportunity around an HCP, but also uncover new pathways for strategic referrals towards those HCPs,” said Megan Wilson, director of product management at AcuityMD. “By identifying the doctors seeing the highest number of relevant patients and leveraging Referral Pathways, Care Journeys can help sales teams make smarter connections, and ultimately help ensure that patients receive the best possible care through the latest, most innovative treatments.”
Uncovering Opportunities for Improved Care
Referral Pathways goes beyond traditional referral data to uniquely map upstream HCPs diagnosing the specific conditions in the same location where HCPs offer a company’s therapy. MedTech teams can leverage this to uncover referral connections that even the treating HCP didn’t know existed. For example, Teleflex Incorporated, a global provider of medical technologies that offers solutions across therapy areas, including interventional urology, is leveraging Care Journeys to increase adoption of its minimally invasive UroLift System.
“Over 14 million men in the U.S. are living with symptoms of BPH (enlarged prostate). We know their treatment journey is long, and only a small percentage (3%) elect to have a surgical intervention,” explained Anthony Parrillo, global vice president of marketing at Teleflex. “Referral Pathways allows us to identify the healthcare providers diagnosing BPH most often in a given market, raise their awareness of the UroLift System procedure, and share with them the UroLift physician locator on our website. This new data from AcuityMD has been remarkable in helping us target more effectively and maximize our opportunity to deliver minimally invasive treatment.”
Health Technology Insights: TeleRare Health Launches Virtual Genomic Consult in Minnesota
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
